Literature DB >> 36032466

Contraceptive acceptability and associated factors among young women (15-24) living with HIV/AIDS: a hospital-based study in Kampala, Uganda.

Muzeyi Wani1, Janet Nakigudde2, Hildah Tendo Nansikombi1, Philip Orishaba1, Dennis Kalibbala1, Joan N Kalyango1, Steven M Kiwuwa3.   

Abstract

Introduction: In Uganda, over 43% of all pregnancies among young women (15-24 years) living with HIV are either unwanted or mistimed. Unintended pregnancies account for 21.3% of neonatal HIV infections. The objective was to determine acceptability of contraceptives and associated factors among young women living with HIV attending HIV clinics in Kampala.
Methods: Between February and May 2019, 450 young women attending public HIV clinics (Kisenyi HC IV, Kiswa HC III and Komamboga HC III) in Kampala were systematically enrolled in a cross sectional study and interviewed using structured questionnaires. We used modified Poisson regression to determine the factors associated with acceptability of contraceptive. Data were analyzed using STATA 13.0. Statistical significance was determined at a P values < 0.05.
Results: Contraceptive acceptability was 40.7% (95% CI: 27.6%-53.6%). Older age group (20-24 years) (aPR; 2.42, 95%CI; 1.06-5.52, P = 0.035), age at sex debut ≥ 18 years (aPR;1.25,95%CI; 1.13-1.38, P<0.001), having friend on contraceptives (aPR; 1.90, 95%CI; 1.10 - 3.26; P =0.021) and being married (aPR; 1.20, 95%CI; 1.09 - 1.32, P<0.001) were significantly associated with acceptability of contraceptives.
Conclusion: There is a low acceptability for contraceptives. Younger age group who are not yet married need to be targeted.
© 2022 Wani M et al.

Entities:  

Keywords:  Contraceptive acceptability; HIV/AIDS; Kampala; Uganda; young women

Mesh:

Substances:

Year:  2022        PMID: 36032466      PMCID: PMC9382528          DOI: 10.4314/ahs.v22i1.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   1.108


Introduction

Sub-Saharan Africa (SSA) accounts for 70% of the global human immunodeficiency virus (HIV) burden. Every week, around 7000 young women (15–24 years) become infected with HIV in SSA. Young women are also twice as likely to be living with HIV as men of the same age1. The prevalence of HIV among young women in Uganda is four times that of young men1 and young women have the highest rate of unwanted pregnancy at 43.9% in Uganda2. A study on sexual risk related behaviour among youth 15–24 years living with HIV (LHIV) in central Uganda reported that 45% were sexually active, of these 57% did not use any form of contraception despite wanting to delay pregnancy and 30% had more than one sexual partner in the last six months3. This high risk sexual behaviour together with low usage of contraceptives puts young HIV positive women at risk of unplanned pregnancy4. A survey on uptake of family planning services in Uganda reported that 43% of pregnancies among HIV positive women were either mistimed or unintended5 and unintended pregnancies accounted for 21.3% of neonatal HIV infections6. Although the Uganda national HIV treatment guidelines recommend integration of family planning services into routine HIV care7, uptake among young HIV positive women is still low. The study set out to determine acceptability of contraceptives and its associated factors among young women LHIV in Kampala city HIV clinics. The findings of the study could help reduce unwanted pregnancies among young women LHIV.

Methods

Study design and setting

This was a cross sectional study. The study was conducted at three Kampala capital city Authority (KCCA) health facilities namely Kisenyi Health centre (HC) IV, Kiswa and Komamboga HC III. All facilities offered a wide range of health care services in addition to HIV care and family planning services. All services offered were free of charge. Kisenyi HC IV had a separate HIV/AIDS clinic for adolescents and young. On average, the weekly attendance by the study participants at Kisenyi HC IV was 80 participants and 60 for Komamboga and Kiswa HCs. These facilities were purposively selected out of 10 HCs in the city due to their busy HIV clinics. The HIV clinic in these facilities runs Monday to Thursday, 8am to 5 pm.

Study population

The study involved 15–24-year-old women LHIV that attended the three KCCA HIV clinics between February and May 2019 and had consented for the study.

Ethics and consent

Permission to conduct the study was obtained from the Clinical Epidemiology Unit, MakCHS; institutional approval was obtained from the Makerere University School of Medicine Research thics Committee (SOMREC). Approval was granted ref no. REC 2019-032. Administrative permission was obtained from the directorate of public health KCCA and permission to access study participants was granted by facility in charges. All participants were requested to consent before participating in the study. Participants younger than 18 years were treated as emancipated minors. Confidentiality was ensured by using unique identifiers for participants.

Sample size

Kish Leslie 1965 was used to calculate sample size as follows, Using a contraceptive acceptability of 52% 2 and precision of 0.05, assuming a 95% level of confidence, we obtained a sample size of 385 participants and a final sample size of 443 participants when adjusted for 15% non-responsiveness.

Sampling

Participants were enrolled systematically. On each study day, every 5th eligible participant at the HIV clinic during the study period was selected. Each facility contributed a proportionate sample to the total sample size based on the total number of clients from each facility as a proportion of the total number of all clients in the three facilities. We, therefore recruited 192 participants from Kisenyi HC IV, 142 participants from Kiswa HC III and 116 participants from Komamboga HC III.

Data collection and management

Between February and May 2019, 450 participants were enrolled. Data from each facility was collected using an interviewer administered questionnaire. The whole questionnaire was translated into Luganda, a common language besides English in Kampala. One HIV clinic nurse from each facility was trained on study procedures and recruited as a research assistant. The research assistants administered informed consent and then collected data using a structured questionnaire. The data was coded and then entered using a computer software (EPI data).

Analysis

Data on socio-demographic, clinical and reproductive characteristics were summarized using frequencies and proportions and presented in tables. Acceptability of contraceptives was determined on the basis of the respondent's response to the question “How much do you like the idea of contraceptives for yourself?” This question was previously used by Whitaker et al in studies of an educational intervention regarding IUDs10. Response options were 1(Very acceptable), 2 (Acceptable), 3 (Not sure),4 (Unacceptable) and 5 (Very unacceptable). A binary variable recoding responses 1–2 as acceptable and 3–5 unacceptability was created. To assess associations between the independent variables and acceptability, we used modified Poisson regression with robust standard errors because acceptability was not rare outcome in this study (>25%). Independent variables with a p-value less than 0.2 at bivariate were considered for multivariate analysis. Associations with p-value < 0.05 at multivariate were considered statistically significant. Significant variables were checked for interaction and dropped variables checked for confounding. The results of the analysis are presented in tables 1 to 4. STATA 13.0 was used for the analysis.
Table 1

Social demographic characteristics of 450 young HIV positive women in KCCA HIV clinics

VariableFrequency (n=450)Percent (%)
Age
<2018942.0
>=2026158.0
Education
None4910.9
Primary10222.7
Secondary22149.1
Tertiary7817.3
Occupation
Student18942
Salaried Job7817.3
Self employed6714.9
Unemployed11625.8
Religion
Catholic17839.6
Protestant11124.7
Muslim11124.7
Other*5011.1
Marital status
Single28663.6
Married9120.2
Cohabiting5812.9
Divorced153.3
Stay with parents
NO22550
Yes22550

Others*: 35 Pentecostal/450, 15/450 Jehovah's witness.

Table 4

Multivariate analysis of factors associated with acceptability of contraceptives

VariableCrude PRAdjusted PR95% CIP value
Age
<201.001.00
>=203.292.421.06 – 5.520.035
Age at sex debut
<181.001.00
>=181.671.251.13 – 1.38<0.001
Friends use contraceptives
No1.001.00
Yes2.451.901.10 – 3.260.021
Marital status
Single1.00
Married2.101.201.09 – 1.32<0.001
Cohabiting1.760.990.71 – 1.390.969
Divorced1.530.910.84 – 0.990.029
Social demographic characteristics of 450 young HIV positive women in KCCA HIV clinics Others*: 35 Pentecostal/450, 15/450 Jehovah's witness. Clinical and reproductive characteristics of 450 young HIV positive women in KCCA HIV clinics Bivariate analysis of factors associated with acceptability of contraceptives Bivariate analysis of factors associated with acceptability of contraceptives Multivariate analysis of factors associated with acceptability of contraceptives

Results

Description of study population

A total of 450 participants were interviewed between February and May 2019. Fifty eight percent of the respondents were over 19 years old. Majority of the respondents (49.1%) had secondary level education, 63.6% were single and 30.9% had never had sexual intercourse (Tables 1 & 2).
Table 2

Clinical and reproductive characteristics of 450 young HIV positive women in KCCA HIV clinics

VariableFrequency (n=450)Percent (%)
Viral load suppression
Suppressed37683.6
Not Suppressed7416.4
Ever had sex
No13930.9
Yes31169.1
Age at sex debut
<1816753.7
>=1814446.3
Have regular sex partner
No14436.7
Yes19763.3
Number of sex partner
one21468.8
Multiple9731.2
Ever had an abortion
No25581.9
Yes5618.1
Parity
Nulliparous268.4
para 1–226585.2
>para 2206.4
Talk to partner about contraceptives
No13643.7
Yes17556.3
Friends use contraceptives
No14432.0
Yes30668.0
Contraceptive knowledge
No22672.7
Yes8527.3

Acceptability of contraceptives and its associated factors

Acceptability of contraceptives was 40.7% with 95% confidence interval (CI): 27.6–53.6%). Tables 3a, 3b and 4 show the bivariate and multivariate analysis of factors associated with acceptability of contraceptives: age, age at sex debut, friend uses contraceptives and marital status (married and divorced) were significantly associated with contraceptive acceptability.
Table 3a

Bivariate analysis of factors associated with acceptability of contraceptives

VariableAcceptability of contraceptivesCrude PR95% CIP value
Yes (n=183)No (n=267)
Age
<2033(17.5)156(82.5)1.00
>=20150(57.5)111(42.5)3.293.11–3.48 <0.001
Viral load suppression
Suppressed155(41.2)221(58.8)1.00
Not Suppressed28(37.8)46(62.2)1.090.82–1.450.558
Ever had sex
No27(19.4)112(80.6)1.00
Yes156(50.2)155(49.8)2.581.38–4.84 0.003
Marital status
Single87(30.4)199(69.6)1.00
Married58(63.7)33(36.3)2.101.87–2.34 <0.001
Cohabiting31(53.5)27(46.5)1.761.12–2.75 0.014
Divorced7(46.7)8(53.3)1.531.22–1.92 <0.001
Stay with parents
NO122(54.2)103(45.8)1.00
Yes61(27.1)164(72.9)0.500.35–0.70 <0.001
Table 3b

Bivariate analysis of factors associated with acceptability of contraceptives

VariableContraceptive acceptabilityCrude PR95% CIP value
Yes (n=156)No (n=155)
Age at sex debut(n=311)
<1864(38.3)103(61.7)1.00
>=1892(63.9)52(36.1)1.671.34–2.07<0.001
Have regular sex partner(n=311)
No50(46.9)64(56.1)1.00
Yes106(53.8)91(46.2)1.231.05–1.43 0.009
Number of sex partners(n=311)
one102(47.7)112(52.3)1.00
Multiple54(55.7)43(44.3)1.170.87–1.570.308
Ever had an abortion(n=311)
No128(50.2)127(49.8)1.00
Yes28(50.0)28(50.0)0.990.81–1.21 0.969
Parity(n=311)
Nulliparous12(46.2)14(53.8)1.00
para 1–2131(49.4)134(50.6)1.070.71–1.630.747
>para 213(65.0)7(35.0)1.411.04–1.90 0.025
Friends use contraceptives
No29(20.1)115(79.9)1.00
Yes154(50.3)152(49.7)2.451.16–5.38 0.019
Contraceptive knowledge
No103(45.6)123(54.4)1.00
Yes53(62.4)32(37.6)1.371.11–1.69 0.003

Discussion

Contraceptives acceptability was low. There is generally a low acceptability of contraceptives among young women12. This highlights a lack of awareness about contraceptives in this age group. Age was found to be significantly associated with acceptability of contraceptives where participants older than 20 years were 2.42 times more likely to use contraceptives compared to those younger. A study on knowledge and use of birth control methods by young women13 also reported being under the age of 15 to be associated with no use of contraceptives. This could be because those younger have limited knowledge of contraceptives. There was a gap in comparative literature on the how age is associated with acceptability of contraceptives among age HIV positive women. Age at first sex was significantly associated with contraceptive acceptability. A study on early age at first sex and subsequent contraceptive use gap reported that girls younger than 15 years at the time of first sex were likely to have a gap in contraceptive use14. This is in agreement with the findings of our study. Marital status was significant factor associated with acceptability of contraceptives in the study, married participants were 1.2 times more likely to use contraceptives compared to their single counterparts and divorced participants were 9% less likely to use contraceptives compared to single participants. A study on family planning strategies across age categories15 reported that among women15–24, single women were more likely to use contraceptives compared to the married participants, this is in disagreement with the findings of our study. Another study on Modern contraceptive use among HIV-infected women attending HIV care centres in Togo reported that married women were less likely to use contraceptives. This is contract to our findings. It is important to note that participants of this study had an average age of 34.3 years and this could explain the variation of the findings16. Another factor that was significantly associated with acceptability of contraceptives among was having a friend that uses contraceptives. It has been reported that exposure to information on contraception use can influence use of contraceptives among young women17 and having a friend probably exposes one to information. These findings also agree a findings of a study on barriers and facilitators adolescent females living with HIV face on accessing contraceptives18, it was reported that peer influence was a key factor among adolescents that use contraceptives.

Conclusion

There was a low contraceptives acceptability among young women living with HIV in Kampala city HIV clinics and this presents a challenge to a key component of the HIV control strategy among young women. Contraceptives acceptability was associated with age, age at sex debut, having a friend that uses contraceptives and marital status.

Study limitation

Collecting data from three facilities may have introduced clustering and this could have contributed to random error in the study, this was however minimized by adjusting for clustering in the analysis. The facilities in this study were purposively selected due to their high numbers of ART enrolment and this may have led to selection bias in the study, this was minimized by systematic sampling.
  13 in total

1.  Childbearing and the use of contraceptive methods among married adolescents in Bangladesh.

Authors:  S M Mostafa Kamal
Journal:  Eur J Contracept Reprod Health Care       Date:  2012-01-15       Impact factor: 1.848

2.  Increasing Uptake of HIV, Sexually Transmitted Infection, and Family Planning Services, and Reducing HIV-Related Risk Behaviors Among Youth Living With HIV in Uganda.

Authors:  Lung Vu; Brady Burnett-Zieman; Cecily Banura; Jerry Okal; Margret Elang; Rodgers Ampwera; Georgina Caswell; Diana Amanyire; Jacquelyne Alesi; Eileen Yam
Journal:  J Adolesc Health       Date:  2017-02       Impact factor: 5.012

3.  Under (implicit) pressure: young Black and Latina women's perceptions of contraceptive care.

Authors:  Anu Manchikanti Gomez; Mikaela Wapman
Journal:  Contraception       Date:  2017-07-26       Impact factor: 3.375

4.  Correlates of use of long-acting reversible methods of contraception among adolescent and young adult women.

Authors:  Amy K Whitaker; Annie M Dude; Amy Neustadt; Melissa L Gilliam
Journal:  Contraception       Date:  2010-02-01       Impact factor: 3.375

5.  Early age at first intercourse and subsequent gaps in contraceptive use.

Authors:  Brianna M Magnusson; Saba W Masho; Kate L Lapane
Journal:  J Womens Health (Larchmt)       Date:  2011-10-12       Impact factor: 2.681

6.  Contraceptive Knowledge Assessment: validity and reliability of a novel contraceptive research tool.

Authors:  Meagan Campol Haynes; Nessa Ryan; Mona Saleh; Abigail Ford Winkel; Veronica Ades
Journal:  Contraception       Date:  2016-09-09       Impact factor: 3.375

7.  Sexual risk related behaviour among youth living with HIV in central Uganda: implications for HIV prevention.

Authors:  Racheal Ankunda; Lynn Muhimbuura Atuyambe; Noah Kiwanuka
Journal:  Pan Afr Med J       Date:  2016-05-11

8.  Sociodemographic Factors Associated with the Knowledge and Use of Birth Control Methods in Adolescents before and after Pregnancy.

Authors:  Reyna Sámano; Hugo Martínez-Rojano; Gabriela Chico-Barba; Bernarda Sánchez-Jiménez; Selene Sam-Soto; Ana Lilia Rodríguez-Ventura; Laura Mejía-Luna; Sylvia Sclavo-Melo
Journal:  Int J Environ Res Public Health       Date:  2019-03-20       Impact factor: 3.390

9.  Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study.

Authors:  Issifou Yaya; Akouda Akessiwè Patassi; Dadja Essoya Landoh; Essodjèlouna Manani Bignandi; Kanfitine Kolani; Abdel-Daim Daou Namoro; P'Niwè Massoubayo Patchali; Lihanimpo Djalogue; Didier Koumavi Ekouevi; Bayaki Saka
Journal:  BMJ Open       Date:  2018-04-24       Impact factor: 2.692

10.  Varying family planning strategies across age categories: differences in factors associated with current modern contraceptive use among youth and adult women in Luanda, Angola.

Authors:  Ndola Prata; Suzanne Bell; Karen Weidert; Benjamin Nieto-Andrade; Adelaide Carvalho; Isilda Neves
Journal:  Open Access J Contracept       Date:  2016-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.